You are here

Novo Nordisk

Japan gives initial OK to Novo's insulin combo, Ryzodeg

Fierce Pharma

Thu, 12/27/12 - 10:32 pm

The Next Wave of Diabetes Dominance

Motley Fool

Wed, 12/12/12 - 08:11 am

Bristol-Myers Squibb

This Top Big Pharma Stock Just Got an Upgrade

Motley Fool

Sat, 12/8/12 - 11:31 am

Glaxo Doubts GLP-1s Would Be Cleared as Drugs for Obesity

Bloomberg

Tue, 12/4/12 - 11:55 am

Novo Nordisk says new data show Victoza advantage

Reuters

Tue, 11/27/12 - 10:36 am

Novo Nordisk A/S: Catching The Increasing Diabetes Trend

Seeking Alpha

Tue, 11/20/12 - 11:27 am

Bristol-Myers Squibb

Teva Is Still Healthier Than Its Big Pharma Peers

Seeking Alpha

Thu, 11/15/12 - 10:47 am

Bristol-Myers Squibb

Degludec And Liraglutide: 2 Drivers Of Novo Nordisk's Growth

Seeking Alpha

Tue, 11/13/12 - 12:11 pm

This Week in Biotech: Part 1

Motley Fool

Sun, 11/11/12 - 09:17 am

Corcept Therapeutics

Novo Aims for Tresiba U.S. Approval in First Half of 2013

Bloomberg

Fri, 11/9/12 - 11:07 am

FDA panel recommends approval of Novo degludec insulin

Reuters

Thu, 11/8/12 - 09:52 pm

advisory panels

Why Investors Are Voting Against Novo Nordisk

Motley Fool

Wed, 11/7/12 - 11:55 am

advisory panels

5 Companies Dominating Diabetes

Motley Fool

Tue, 11/6/12 - 04:21 pm

Bristol-Myers Squibb

5 Things to Watch This Week in the Health-Care Sector

Motley Fool

Tue, 11/6/12 - 12:28 pm

FDA staff highlight heart risk with Novo insulin

Reuters

Tue, 11/6/12 - 10:12 am

Novo hikes forecast on 62% jump in Victoza sales

Fierce Pharma

Wed, 10/31/12 - 11:14 am

2012's Best Pharmaceutical Stock

Motley Fool

Sun, 10/28/12 - 11:50 am

Novo Nordisk says FDA disclosed focus of upcoming panel meeting

The Fly on the Wall

Fri, 10/26/12 - 10:32 am

advisory panels

FDA panel to weigh heart safety of Novo's new insulin

Reuters

Thu, 10/25/12 - 05:33 pm

advisory panels

Novo Nordisk: Encouraging Pipeline News

Seeking Alpha

Tue, 10/23/12 - 09:13 am

Pages